IMMUNOGENIC VACCINE COMPOSITION INCORPORATING A SAPONIN Application WO-2024052882-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
VARIANT STRAIN-BASED CORONAVIRUS VACCINES AND USES THEREOF Application WO-2024050483-A1 World Intellectual Property Organisation (WIPO) 07 Mar 2024
ANTIGENIC DETERMINANTS, PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS… Application WO-2023094885-A2 World Intellectual Property Organisation (WIPO) 01 Jun 2023
CODON OPTIMIZATION OF NUCLEIC ACIDS Application WO-2023002492-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2023
IMMUNE CELL COUNTING OF SARS-COV-2 PATIENTS BASED ON IMMUNE REPERTOIRE SEQUENCING Application WO-2022207682-A1 World Intellectual Property Organisation (WIPO) 06 Oct 2022
INDUCTION OF IMMUNITY TO SARS-COV-2 IN CHILDREN Application WO-2022197209-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
DRY POWDER FORMULATIONS OF NUCLEIC ACID LIPID NANOPARTICLES Application WO-2022192239-A1 World Intellectual Property Organisation (WIPO) 15 Sep 2022
NUCLEIC ACID MOLECULES AND VACCINES COMPRISING SAME FOR THE PREVENTION AND TREATMENT OF… Application WO-2022192594-A2 World Intellectual Property Organisation (WIPO) 15 Sep 2022
NOVEL COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE Application WO-2022178545-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155524-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155530-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
LIVE-ATTENUATED RNA HYBRID VACCINE TECHNOLOGY Application WO-2022051023-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
CO-LYOPHILIZED RNA AND NANOSTRUCTURED LIPID CARRIER Application WO-2022051022-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
GENETICALLY-ADJUVANTED RNA VACCINES Application WO-2022051024-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
NUCLEIC ACID LIPID PARTICLE VACCINE Application WO-2021251453-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
DRUG APPLICATION FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY… Application RU-2761904-C1 Russian Federation 13 Dec 2021
A METHOD FOR DETERMINING THE EFFICACY OF A SARS-COV-2 VACCINE Application WO-2021229078-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
CORONAVIRUS RNA VACCINES AND METHODS OF USE Application WO-2021159130-A3 World Intellectual Property Organisation (WIPO) 18 Nov 2021
A METHOD FOR DETERMINING THE EFFICACY OF A SARS-COV-2 VACCINE Application EP-3855186-A2 European Patent Office 28 Jul 2021
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Application WO-2021119497-A1 World Intellectual Property Organisation (WIPO) 17 Jun 2021